In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity

scientific article (publication date: July 1999)

In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1054/PLEF.1999.0074
P698PubMed publication ID10477044

P2093author name stringS Van Horn
D C Underwood
H M Sarau
J J Foley
D W Hay
L D Martin
P A Chambers
G M Sathe
D E Griswold
E F Webb
M Chabot-Fletcher
D R Jakas
D B Schmidt
M N Tzimas
I Pendrak
W D Kingsbury
J J Breton
R A Daines
P2860cites workA G-protein-coupled receptor for leukotriene B4 that mediates chemotaxisQ24308699
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
P304page(s)55-64
P577publication date1999-07-01
P1433published inProstaglandins, Leukotrienes and Essential Fatty AcidsQ15753414
P1476titleIn vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity
P478volume61

Reverse relations

cites work (P2860)
Q34097380Eicosanoids in inflammatory skin diseases
Q37016080The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field